MEI Pharma, Inc. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported net loss was USD 11.06 million compared to net income of USD 10.25 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to basic earnings per share from continuing operations of USD 1.54 a year ago.
For the six months, sales was USD 0.752 million compared to USD 41.47 million a year ago. Revenue was USD 65.3 million compared to USD 41.47 million a year ago. Net income was USD 45.31 million compared to net loss of USD 6.37 million a year ago. Basic earnings per share from continuing operations was USD 6.8 compared to basic loss per share from continuing operations of USD 0.96 a year ago.